|
|
||||||||
Department of Molecular Pharmacology, Merck Research Laboratories, West Point, Pennsylvania 19486
We established HEK-293 cell lines that
stably express functional canine ether-à-go-go-related
gene (cERG) K+ channels and examined their biophysical and
pharmacological properties with whole cell patch clamp and
35S-labeled MK-499 ([35S]MK-499) binding
displacement. Functionally, cERG current had the hallmarks of cardiac
delayed rectifier K+ current (IKr).
Channel opening was time- and voltage dependent with threshold near
40 mV. The half-maximum activation voltage was
7.8 ± 2.4 mV
at 23°C, shifting to
31.9 ± 1.2 mV at 36°C. Channels
activated with a time constant of 13 ± 1 ms at +20 mV, showed
prominent inward rectification at depolarized potentials, were highly
K+ selective (Na+-to-K+
permeability ratio = 0.007), and were potently inhibited by
IKr blockers. Astemizole, terfenadine,
cisapride, and MK-499 inhibited cERG and human ERG (hERG) currents with
IC50 values of 1.3, 13, 19, and 15 nM and 1.2, 9, 14, and
21 nM, respectively, and competitively displaced
[35S]MK-499 binding from cERG and hERG with
IC50 values of 0.4, 12, 35, and 0.6 nM and 0.8, 5, 47, and
0.7 nM, respectively. cERG channels had biophysical properties
appropriate for canine action potential repolarization and were
pharmacologically sensitive to agents known to prolong QT. A novel
MK-499 binding assay provides a new tool to detect agents affecting ERG channels.
ion channels; acquired long QT syndrome, potassium ion channel; ventricular arrhythmia; canine ether-à-go-go-related gene
This article has been cited by other articles:
![]() |
Y. Zhu, J. Ye, and J. D. Huizinga Clotrimazole-sensitive K+ currents regulate pacemaker activity in interstitial cells of Cajal Am J Physiol Gastrointest Liver Physiol, June 1, 2007; 292(6): G1715 - G1725. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Guth Preclinical Cardiovascular Risk Assessment in Modern Drug Development Toxicol. Sci., May 1, 2007; 97(1): 4 - 20. [Full Text] [PDF] |
||||
![]() |
A. Finkel, A. Wittel, N. Yang, S. Handran, J. Hughes, and J. Costantin Population Patch Clamp Improves Data Consistency and Success Rates in the Measurement of Ionic Currents J Biomol Screen, August 1, 2006; 11(5): 488 - 496. [Abstract] [PDF] |
||||
![]() |
H. Morita, D. P. Zipes, J. Lopshire, S. T. Morita, and J. Wu T wave alternans in an in vitro canine tissue model of Brugada syndrome Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H421 - H428. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Guthrie, F. S. Livingston, U. Gubler, and R. Garippa A Place for High-Throughput Electrophysiology in Cardiac Safety: Screening hERG Cell Lines and Novel Compounds with the Ion Works HTTM System J Biomol Screen, December 1, 2005; 10(8): 832 - 840. [Abstract] [PDF] |
||||
![]() |
J.M. Cordeiro, R. Brugada, Y.S. Wu, K. Hong, and R. Dumaine Modulation of IKr inactivation by mutation N588K in KCNH2: A link to arrhythmogenesis in short QT syndrome Cardiovasc Res, August 15, 2005; 67(3): 498 - 509. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dorn, F. Hermann, A. Ebneth, H. Bothmann, G. Trube, K. Christensen, and C. Apfel Evaluation of a High-Throughput Fluorescence Assay Method for hERG Potassium Channel Inhibition J Biomol Screen, June 1, 2005; 10(4): 339 - 347. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |